<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00765713</url>
  </required_header>
  <id_info>
    <org_study_id>HULP PI-719</org_study_id>
    <nct_id>NCT00765713</nct_id>
  </id_info>
  <brief_title>Sleep Apnea-hypopnea Syndrome (SAHS) and Ventricular Arrhythmias</brief_title>
  <acronym>SAHS-ICD</acronym>
  <official_title>Sleep Apnea-hypopnea Syndrome and Ventricular Arrhythmias in Patients With Systolic Ventricular Dysfunction and Implantable Cardioverter-defibrillator. Incidence and Effect of CPAP Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Universitario La Paz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Virgen de la Salud</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Hospital Universitario Virgen Macarena</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospital Universitario La Paz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypothesis:

      The CPAP treatment diminishes the effect of ventricular arrhythmias in patients with ischemic
      heart disease or dilated myocardiopathy, systolic ventricular disfunction and sleep
      apnea-hypopnea syndrome (SAHS)Objectives: To analyze the incidence of ventricular arrhythmias
      (premature ventricular beat, non-sustained ventricular tachycardia and sustained ventricular
      tachycardia) and appropriate defibrillator therapies in patients with ischemic heart disease
      or dilated myocardiopathy, moderate-severe left ventricular dysfunction,with an implantable
      cardioverter-defibrillator (ICD) and sleep apnea. To study the effect of CPAP on the cardiac
      arrhythmias and on the number of appropriate defibrillator therapies.

      Design:

      Parallel, randomized and single-blinded multicentric study to compare CPAP vs.
      hygienic-dietetic recommendations.

      Patients with SAHS (AHI≥15) and systolic left ventricle dysfunction patients with an ICD.

      Duration: 24 months.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Secondary objectives:

      To compare the prevalence of SAHS in patients with ischemic heart disease or dilated
      myocardiopathy and moderate-severe left ventricle dysfunction with ICD with that of the
      general population. To study the incidence of supraventricular arrhythmias (atrial
      fibrillation, atrial flutter or supraventricular tachycardia) and inappropriate defibrillator
      therapies in these patients. To value the effect of the treatment with CPAP on the above
      mentioned arrhythmias. To relate the effect of ventricular and supraventricular arrhythmias
      with sleep parameters, cardiovascular biomarkers, inflammation and oxidative stress. To
      evaluate the long-term effect of the CPAP on systemic biomarkers in patients with ischemic
      heart disease or dilated myocardiopathy and moderate-severe left ventricle dysfunction. To
      evaluate the long-term effect of CPAP on the quality of life in these patients.

      Sample size:

      224 patients with ischemic heart disease or dilated myocardiopathy and moderate-severe left
      ventricle dysfunction with ICD will be included to randomize 19 SAHS subjects for arm.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2008</start_date>
  <completion_date type="Actual">January 2013</completion_date>
  <primary_completion_date type="Actual">October 2012</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of appropriate defibrillator therapies</measure>
    <time_frame>24 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>AHI, incidence of premature ventricular beats and non-sustained ventricular tachycardia. Plasmatic levels of C-reactive protein, homocystein, pro-BNP, sTNFαR-I, IL-1b, IL-2, IL-6, IL-8, IL-8 and 8-isoprostane</measure>
    <time_frame>24 moths</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">224</enrollment>
  <condition>Sleep Apnea</condition>
  <condition>Ventricular Arrythmias</condition>
  <condition>Systolic Left Ventricle Dysfunction</condition>
  <arm_group>
    <arm_group_label>CPAP</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Continuous positive airway pressure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Conventional</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Hygienic-dietetic recommendations</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Nasal continuous positive airway pressure</intervention_name>
    <description>Nocturnal</description>
    <arm_group_label>CPAP</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Previous diagnostic of ischaemic heart disease of dilated myocardiopathy

          -  Ejection fraction of left ventricle &lt; 40%

          -  Patients with implantable cardioverter-defibrillator

        Exclusion Criteria:

          -  Diurnal hypersomnolence with EES &gt; 16

          -  Morbid obesity (BMI &gt; 35 Kg/m2).

          -  Moderate-severe chronic obstructive pulmonary disease (FEV1/FVC &lt; 70 % and FEV1 &lt; 80 %
             of reference).

          -  Known thyroid disease.

          -  Previous treatment with CPAP.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Francisco Garcia-Rio, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Universitario La Paz</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Universitario La Paz</name>
      <address>
        <city>Madrid</city>
        <zip>28046</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de la Macarena</name>
      <address>
        <city>Sevilla</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Hospital Virgen de la Salud</name>
      <address>
        <city>Toledo</city>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>September 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 2, 2008</study_first_submitted>
  <study_first_submitted_qc>October 2, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 3, 2008</study_first_posted>
  <last_update_submitted>April 1, 2013</last_update_submitted>
  <last_update_submitted_qc>April 1, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 2, 2013</last_update_posted>
  <responsible_party>
    <name_title>Rafael Peinado Peinado</name_title>
    <organization>Hospital Universitario La Paz</organization>
  </responsible_party>
  <keyword>Sleep apnea</keyword>
  <keyword>CPAP</keyword>
  <keyword>Ventricular arrhythmias</keyword>
  <keyword>Defibrillator therapies</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Apnea</mesh_term>
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

